Table 1.
Analyzed datasets
| ID | Total | Cases | Controls | Paired | Description |
|---|---|---|---|---|---|
| BLCA | 271 | 252 | 19 | 19 | Bladder Urothelial Carcinoma |
| BRCA | 807 | 720 | 87 | 86 | Breast invasive carcinoma |
| CESC | 218 | 215 | 3 | 3 | Cervical squamous cell carcinoma |
| COAD | 243 | 235 | 8 | 0 | Colon adenocarcinoma |
| ESCA | 113 | 102 | 11 | 11 | Esophageal carcinoma |
| HNSC | 519 | 475 | 44 | 43 | Head and Neck squamous cell carcinoma |
| KICH | 91 | 66 | 25 | 25 | Kidney Chromophobe |
| KIRC | 311 | 240 | 71 | 68 | Kidney renal clear cell carcinoma |
| KIRP | 245 | 211 | 34 | 34 | Kidney renal papillary cell carcinoma |
| LIHC | 283 | 233 | 50 | 49 | Liver hepatocellular carcinoma |
| LUAD | 474 | 428 | 46 | 39 | Lung adenocarcinoma |
| LUSC | 376 | 331 | 45 | 45 | Lung squamous cell carcinoma |
| PAAD | 100 | 96 | 4 | 4 | Pancreatic adenocarcinoma |
| PCPG | 182 | 179 | 3 | 3 | Pheochromocytoma and Paraganglioma |
| PRAD | 117 | 100 | 17 | 17 | Prostate adenocarcinoma |
| READ | 93 | 90 | 3 | 0 | Rectum adenocarcinoma |
| SKCM | 75 | 74 | 1 | 0 | Skin Cutaneous Melanoma |
| STAD | 345 | 306 | 39 | 39 | Stomach adenocarcinoma |
| THCA | 558 | 499 | 59 | 59 | Thyroid carcinoma |
| UCEC | 418 | 386 | 32 | 19 | Uterine Corpus Endometrial Carcinoma |
Columns of the table display: TCGA disease ID, the total number of samples in the analysis, the number of tumoral samples, the number of control samples (solid normal tissue), the number of paired samples available in the dataset and the cancer type.